Related Experiment Video
Updated: Feb 7, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Prognostic value of pre-therapy C-reactive protein level in diffuse large B-cell lymphoma: a meta-analysis
Wenqiong Qin1, Qiang Yuan2, Jingkui Wu3
1a Department of PET/CT Diagnostic , Tianjin Medical University General Hospital , Heping District , Tianjin , China.
Abstract:
The current meta-analysis was conducted aiming to explore the association between pre-therapy CRP and DLBCL survival outcomes. We retrieved previously published studies available from PubMed, EMBASE, Web of Science, The Cochrane Library, Wanfang databases, and China National Knowledge Infrastructure databases by June 2017. A total of 12 studies composed of 3000 patients were included in this study according to our selection criteria. The pooled HRs of elevated pre-therapy CRP were 2.66 (95% CI = 1.95-3.64, p < .001) for OS while 2.19 (95% CI = 1.72-2.78, p < .001) for PFS. Sensitivity analysis and subgroup analysis indicated that CRP remained a prognostic biomarker for OS and PFS. The pooled HR was 3.01 (95% CI = 2.38-3.81, p < .001) for OS if excluding 3 heterogeneous studies, and the heterogeneity decreased from 59.6% to 11.2%. Our study revealed that pre-therapy CRP can be a potential prognostic marker for patients with DLBCL.
Related Concept Videos
Protein Diffusion in the Membrane
Diffusion
Diffusion
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Gene Therapy
Directing Effect of Substituents: meta-Directing Groups

